This article is a correction to:
Benefits and risks of antihypertensive medication in adults with different systolic blood pressure: A meta-analysis from the perspective of the number needed to treat
Yucheng Mao
Qing-Bao Tian- Hebei Key Laboratory of Environment and Human Health, Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University, Shijiazhuang, China
by Mao, Y., Ge, S., Qi, S., and Tian, Q. B. (2022). Front. Cardiovasc. Med. 9:986502. doi: 10.3389/fcvm.2022.986502
In the published article, there was an error in Figure 2 as published. The wrong color was used for the visualization of the result in the figure. The numbers of colored faces were inconsistent with some of the results. The corrected Figure 2 and its caption appear below.
FIGURE 2
Figure 2. Cates plot of the NNTs for primary outcomes across different SBP levels and cardiovascular diseases status. Each region is the value of NNT of MACEs or AEs in one SBP level and includes 100 faces corresponding to the patients treated with antihypertensive medication. Green faces mean patients not occurring MACEs or AEs with the treatment. Red faces indicate that patients presenting MACEs or AEs with the treatment. Yellow faces represent patients that would not have MACEs or AEs if they would be treated with the treatment. Crossed green faces present patients not fulfilled MACEs or AEs with a control group. Mean follow-up duration was 3.50 years.
In the published article, there was a clerical error in a formula.
A correction has been made to Materials and methods, “Statistical analysis,” paragraph 2. This formula previously stated:
The corrected formula appears below:
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: blood pressure threshold, pharmacological treatment, number needed to treat, cost-effectiveness, cardiovascular endpoint
Citation: Mao Y, Ge S, Qi S and Tian Q-B (2022) Corrigendum: Benefits and risks of antihypertensive medication in adults with different systolic blood pressure: A meta-analysis from the perspective of the number needed to treat. Front. Cardiovasc. Med. 9:1094336. doi: 10.3389/fcvm.2022.1094336
Received: 10 November 2022; Accepted: 25 November 2022;
Published: 05 December 2022.
Edited and reviewed by: Maddalena Illario, University of Naples Federico II, Italy
Copyright © 2022 Mao, Ge, Qi and Tian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qing-Bao Tian, dHFiMTk4MCYjeDAwMDQwO2hlYm11LmVkdS5jbg==